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Introduction
Fasting is a recognized trigger of headache in susceptible
individuals. Leptin is a peptide hormone encoded by the
mouse obese gene (ob)[1] and is mainly secreted by white
adipocytes. Plasma levels of leptin are regulated to reflect
body energy stores: levels of leptin fall in response to fast-
ing and are increased in several models of murine obesity
[2]. Leptin signaling decreases feeding and increases
energy expenditure by activating the longform of its recep-
tor (LepRb) in areas of the brain[3] including the brain-
stem, midbrain, hypothalamus, thalamus and cortex[4].
Aim
To study the effect of acute administration of leptin on
activity in the trigeminocervical complex (TCC) in
response to middle meningeal artery (MMA) stimulation.
Methods
Adult male Sprague-Dawley rats were anesthetized with
pentobarbitone (60 mgkg-1) and cannulated for measure-
ment of blood pressure and intravenous administration of
supplementary anesthesia with propofol (15-20 mgkg-1hr-
1). The parietal bone was removed over the MMA for
electrical stimulation of the dura mater and electrophysio-
logical recording of second order neurons in the TCC
using a tungsten electrode. Rats received either rat recom-
binant leptin in a dosage of 1 mgkg-1 (i.v.) dissolved in
sterile water, or sterile water alone as the control group.
The effects of leptin on TCC activity in response to MMA
stimulation were recorded.
Results
Leptin significantly reduced cell firing in response to tri-
geminovascular activation within the TCC (p < 0.05).
This effect reached a maximum inhibition of nearly 12%
at 45 minutes post-infusion of leptin. Infusion of sterile
water alone had no significant effect on MMA stimula-
tion-evoked firing.
Conclusion
The data show leptin treatment inhibits stimulus-evoked
trigeminal activity, which might explain, in part, why fast-
ing, a condition characterized by low levels of circulating
leptin, may have a role in headache. Exploring the interac-
tion between feeding physiology and trigeminovascular
nociceptive mechanisms may contribute to our under-
standing of this very common trigger.
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